Filing Details
- Accession Number:
- 0001104659-12-044219
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-06-18 21:25:23
- Reporting Period:
- 2012-06-14
- Filing Date:
- 2012-06-18
- Accepted Time:
- 2012-06-18 21:25:23
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 881524 | Vivus Inc | VVUS | Pharmaceutical Preparations (2834) | 943136179 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1251107 | Y Peter Tam | 1172 Castro Street Mountain View CA 94040 | President | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2012-06-14 | 60,000 | $25.25 | 37,629 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- Includes 1,408 shares acquired under the VIVUS, Inc. Employee Stock Purchase Plan on May 14, 2012
- The sale price reported in column 4 of Table I represents the weighted average sale price of the shares sold ranging from $24.90 to $25.53 per share. Upon request by the Commission staff, the Issuer, or a sercurity holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
- The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 17, 2011, as amended.
Billionaire Hedge Funds
